The notices it replaced
- Reissues: PAR-23-097 Mood and Psychosis Symptoms during the Menopause Transition (R01 Clinical Trial Optional)
- 2 steps back: PAR-22-035 Mood and Psychosis Symptoms during the Menopause Transition (R01 Clinical Trial Optional)
- 3 steps back: RFA-MH-21-105 Mood and Psychosis Symptoms during the Menopause Transition (R01 Clinical Trial Optional)
Who won it before
8 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $6,695,854 in first-year total cost, median $804,067.
Most frequent study sections
- Special Emphasis Panel[ZMH1 ERB-N (07)]4
- Biobehavioral Mechanisms of Emotion, Stress and Health Study Section[MESH]2
- Adult Psychopathology and Disorders of Aging Study Section[APDA]1
- Neural Basis of Psychopathology, Addictions and Sleep Disorders Study Section[NPAS]1
Most frequent institutions
- BRIGHAM AND WOMEN'S HOSPITAL1
- EMORY UNIVERSITY1
- ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI1
- MICHIGAN STATE UNIVERSITY1
- UNIV OF NORTH CAROLINA CHAPEL HILL1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2025 | The immunobiological mechanisms of depression in perimenopause1R01MH139201-01 · under PAR-23-097 | ACHTYES, ERIC DANIELBRUNDIN, LENA CECILIAOSBORNE, LAUREN MYOUSSEF, NAGY A. | VAN ANDEL RESEARCH INSTITUTE, MI | $919,453 | MESH |
| 2024 | Hormonal Drivers of Perimenopausal Inflammation and Mood Symptoms1R01MH135079-01A1 · under PAR-23-097 | SPICER, JULIE A | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI, NY | $910,241 | MESH |
| 2024 | Chronobiological Basis of Depression during the Menopause Transition1R01MH134120-01A1 · under PAR-23-097 | PARRY, BARBARA L | UNIVERSITY OF CALIFORNIA, SAN DIEGO, CA | $777,135 | NPAS |
| 2023 | PREMAP - Predictors and Risk Evaluation for Menopause-Associated Psychosis1R01MH131768-01 · under PAR-22-035 | POWERS, ALBERT R | YALE UNIVERSITY, CT | $822,665 | APDA |
| 2022 | Using allopregnanolone to probe behavioral and neurobiological mechanisms that underlie depression in women across perimenopausal stage1R01MH128617-01 · under RFA-MH-21-105 | BURDICK, KATHERINE ELIZABETHJOFFE, HADINE | BRIGHAM AND WOMEN'S HOSPITAL, MA | $947,753 | ZMH1 |
| 2022 | Hormonal Mechanisms of Perimenopausal Risk for Psychosis in Women1R01MH128196-01 · under RFA-MH-21-105 | CULBERT, KRISTENKLUMP, KELLY LTHAKKAR, KATHARINE NATASHA | MICHIGAN STATE UNIVERSITY, MI | $785,469 | ZMH1 |
| 2022 | Examining the Effects of Estradiol on Neural and Molecular Response to Rewards in Perimenopausal-Onset Anhedonia and Psychosis1R01MH128238-01 · under RFA-MH-21-105 | DICHTER, GABRIEL SLALUSH, DAVID SSCHILLER, CRYSTAL EDLER | UNIV OF NORTH CAROLINA CHAPEL HILL, NC | $771,097 | ZMH1 |
| 2022 | Neuroendocrine Mechanisms Underlying Perimenopausal Risk for Trauma-Related Hyperarousal in Black Women1R01MH128244-01 · under RFA-MH-21-105 | MICHOPOULOS, VASILIKISTEVENS, JENNIFER STRAFFORD | EMORY UNIVERSITY, GA | $762,041 | ZMH1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.